These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21205435)

  • 1. Neural correlates of treatment outcome in major depression.
    Lisiecka D; Meisenzahl E; Scheuerecker J; Schoepf V; Whitty P; Chaney A; Moeller HJ; Wiesmann M; Frodl T
    Int J Neuropsychopharmacol; 2011 May; 14(4):521-34. PubMed ID: 21205435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
    McGrath PJ; Stewart JW; Fava M; Trivedi MH; Wisniewski SR; Nierenberg AA; Thase ME; Davis L; Biggs MM; Shores-Wilson K; Luther JF; Niederehe G; Warden D; Rush AJ
    Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder.
    Benkert O; Szegedi A; Philipp M; Kohnen R; Heinrich C; Heukels A; van der Vegte-Senden M; Baker RA; Simmons JH; Schutte AJ
    J Clin Psychopharmacol; 2006 Feb; 26(1):75-8. PubMed ID: 16415711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neural substrates of affective processing in depressed patients treated with venlafaxine.
    Davidson RJ; Irwin W; Anderle MJ; Kalin NH
    Am J Psychiatry; 2003 Jan; 160(1):64-75. PubMed ID: 12505803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart rate variability during antidepressant treatment with venlafaxine and mirtazapine.
    Terhardt J; Lederbogen F; Feuerhack A; Hamann-Weber B; Gilles M; Schilling C; Lecei O; Deuschle M
    Clin Neuropharmacol; 2013; 36(6):198-202. PubMed ID: 24201230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
    Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
    J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased platelet count after treatment with venlafaxine or mirtazapine in depressed patients.
    Gronau W; Paslakis G; Lederbogen F; Weber-Hamann B; Gilles M; Schilling C; Deuschle M
    Pharmacopsychiatry; 2015 Jan; 48(1):37-9. PubMed ID: 25402815
    [No Abstract]   [Full Text] [Related]  

  • 8. Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report.
    Sung SC; Wisniewski SR; Balasubramani GK; Zisook S; Kurian B; Warden D; Trivedi MH; Rush AJ;
    Psychol Med; 2013 May; 43(5):945-60. PubMed ID: 23228340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antidepressants and their onset of action: a major clinical, methodological and pronostical issue].
    Gourion D
    Encephale; 2008 Jan; 34(1):73-81. PubMed ID: 18514154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: a randomised open trial.
    Scharnholz B; Weber-Hamann B; Lederbogen F; Schilling C; Gilles M; Onken V; Frankhauser P; Kopf D; Deuschle M
    Psychiatry Res; 2010 May; 177(1-2):109-13. PubMed ID: 20381159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
    Blier P; Ward HE; Tremblay P; Laberge L; Hébert C; Bergeron R
    Am J Psychiatry; 2010 Mar; 167(3):281-8. PubMed ID: 20008946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial.
    Kang EH; Lee IS; Chung SK; Lee SY; Kim EJ; Hong JP; Oh KS; Woo JM; Kim S; Park JE; Yu BH
    Psychiatry Res; 2009 Sep; 169(2):118-23. PubMed ID: 19695711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant functional connectivity of dorsolateral prefrontal and cingulate networks in patients with major depression during working memory processing.
    Vasic N; Walter H; Sambataro F; Wolf RC
    Psychol Med; 2009 Jun; 39(6):977-87. PubMed ID: 18845009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
    Zisook S; Lesser IM; Lebowitz B; Rush AJ; Kallenberg G; Wisniewski SR; Nierenberg AA; Fava M; Luther JF; Morris DW; Trivedi MH
    J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between changes in sustained fronto-striatal connectivity and positive affect in major depression resulting from antidepressant treatment.
    Heller AS; Johnstone T; Light SN; Peterson MJ; Kolden GG; Kalin NH; Davidson RJ
    Am J Psychiatry; 2013 Feb; 170(2):197-206. PubMed ID: 23223803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontal and rostral anterior cingulate (rACC) theta EEG in depression: implications for treatment outcome?
    Arns M; Etkin A; Hegerl U; Williams LM; DeBattista C; Palmer DM; Fitzgerald PB; Harris A; deBeuss R; Gordon E
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1190-200. PubMed ID: 25936227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combining venlafaxine and mirtazapine for the treatment of major depression with dysthymia--"double depression"].
    Ladeira RB; Cunha FT; Salgado JV; Teixeira AL; Nicolato R
    Braz J Psychiatry; 2008 Sep; 30(3):299-300. PubMed ID: 18833439
    [No Abstract]   [Full Text] [Related]  

  • 18. Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study.
    Frodl T; Scheuerecker J; Schoepf V; Linn J; Koutsouleris N; Bokde AL; Hampel H; Möller HJ; Brückmann H; Wiesmann M; Meisenzahl E
    J Clin Psychiatry; 2011 Apr; 72(4):448-57. PubMed ID: 20868630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care.
    Warden D; Trivedi MH; Carmody T; Toups M; Zisook S; Lesser I; Myers A; Kurian KR; Morris D; Rush AJ
    J Psychiatr Pract; 2014 Mar; 20(2):118-32. PubMed ID: 24638046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of serum concentrations of brain-derived neurotrophic factor (BDNF) during treatment with venlafaxine and mirtazapine: role of medication and response to treatment.
    Deuschle M; Gilles M; Scharnholz B; Lederbogen F; Lang UE; Hellweg R
    Pharmacopsychiatry; 2013 Mar; 46(2):54-8. PubMed ID: 22961097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.